IMVT 241115 30.00C (IMVT241115C30000) Stock Options, News & Quotes

US OptionsDetailed Quotes

IMVT241115C30000

Watchlist

0.05
-0.14-73.68%

15min DelayClose Nov 15 15:57 ET

0.05High0.05Low

Intraday

5D
Daily

News

Argenx Upgraded at Wolfe on Myasthenia Gravis Dominance
Seeking AlphaNov 12 11:03 ET
Immunovant's Strategic Advances in Autoimmune Therapies
TipRanksNov 8 23:22 ET
H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $51
Moomoo NewsNov 8 12:32 ET · Ratings
Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus
Zacks Nov 8 10:05 ET
A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $48 to $58
Moomoo NewsNov 8 08:00 ET · Ratings
Immunovant's Promising Pipeline and Strategic Advancements Justify Buy Rating
TipRanksNov 7 16:55 ET · Ratings

Comments

Meltyy

May 16 01:29

🔔 Perceptive Advisors Q1 ‘24* Holdings Released... 🐳

» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
...

frankinglily

Apr 1 03:50

Updated Complete & Utter M&A Guesses Purely for Entertainment Purposes:

$SPDR S&P Biotech ETF (XBI.US)$
$Merck & Co (MRK.US)$ x $Immunovant (IMVT.US)$
$Eli Lilly and Co (LLY.US)$ x $Cytokinetics (CYTK.US)$ (and soon)
$Regeneron Pharmaceuticals (REGN.US)$ x $Apellis Pharmaceuticals (APLS.US)$ (panache & brash)
$Gilead Sciences (GILD.US)$ x % $Madrigal Pharmaceuticals (MDGL.US)$ (liver king)
$Bristol-Myers Squibb (BMY.US)$ x $Iovance Biotherapeutics (IOVA.US)$ (cell Tx boost needed)
$Eli Lilly and Co (LLY.US)$ x $Merus (MRUS.US)$ (partner n...

Moomoo AI

Nov 20, 2023 06:18

Insider selling of shares when the price was below the current rate raises eyebrows. The recent trend of insiders selling shares might worry investors, despite insiders owning about 0.6% of company shares, implying some shareholder alignment.

Immunovant Insiders Sell US$9.8m Of Stock, Possibly Signalling Caution

Mooers Radar

Oct 9, 2023 04:01

Columns Weekly Insider Money Tracking: IMVT director undertook a $58 million buy, and AAPL executives sold over $64 million in stocks.

1 | Below is a look at the top insider trades with the biggest value in the past week.
One of $Immunovant (IMVT.US)$'s directors and more than 10% owner, $Roivant Sciences (ROIV.US)$, recently undertook a vast buy transaction worth $58 million. IMVT stock has gained over 104% since the start of this year. It is worth mentioning that Immunovant is a subsidiary of Roivant Sci...

nerdbull1669

Oct 4, 2023 23:19

Immunovant Inc. (IMVT) - FA and TA

$Immunovant (IMVT.US)$ surged after the company announced positive initial results from both cohorts, the single-ascending dose (SAD) portion and the multiple-ascending dose (MAD) portion of its early-stage study of IMVT-1402.
One of the thing I look out for this stock is its debt in the balance sheet, it only have 10% of its total asset, but question remain whether they would be able to sustain cash burn before they turn profitable or rather when will their cash...

TA Challenge: How do you identify trends with moving averages?